LENSAR (LNSR) Revenue & Revenue Breakdown
LENSAR Revenue Highlights
Latest Revenue (Y)
$42.16M
Latest Revenue (Q)
$10.59M
Main Segment (Y)
Product
Main Geography (Y)
UNITED STATES
LENSAR Revenue by Period
LENSAR Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $42.16M | 19.25% |
2022-12-31 | $35.36M | 2.61% |
2021-12-31 | $34.46M | 30.62% |
2020-12-31 | $26.38M | -13.58% |
2019-12-31 | $30.53M | - |
LENSAR Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $10.59M | -12.53% |
2023-12-31 | $12.11M | 23.58% |
2023-09-30 | $9.79M | -18.46% |
2023-06-30 | $12.01M | 45.56% |
2023-03-31 | $8.25M | -19.35% |
2022-12-31 | $10.23M | 32.06% |
2022-09-30 | $7.75M | -3.61% |
2022-06-30 | $8.04M | -13.94% |
2022-03-31 | $9.34M | -16.77% |
2021-12-31 | $11.22M | 35.66% |
2021-09-30 | $8.27M | 4.42% |
2021-06-30 | $7.92M | 12.48% |
2021-03-31 | $7.04M | -14.98% |
2020-12-31 | $8.28M | 15.94% |
2020-09-30 | $7.14M | 41.57% |
2020-06-30 | $5.05M | -14.54% |
2020-03-31 | $5.91M | -30.19% |
2019-12-31 | $8.46M | 4.86% |
2019-09-30 | $8.07M | 15.26% |
2019-06-30 | $7.00M | - |
2019-03-31 | $7.00M | - |
LENSAR Revenue Breakdown
LENSAR Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|
Service | $4.07M | $3.48M | $3.25M | $2.95M |
Product | $31.64M | $25.96M | $26.25M | $19.83M |
Quarterly Revenue by Product
Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Service | $1.21M | $1.05M | $1.11M | $944.00K | $965.00K | $832.00K | $790.00K | $890.00K | $972.00K | $844.00K | $903.00K | $726.00K | $774.00K | $731.00K | $808.00K |
Product | $7.43M | $9.45M | $7.16M | $9.38M | $5.66M | $7.77M | $5.49M | $5.73M | $6.97M | $8.95M | $6.08M | $6.06M | $5.16M | $6.47M | $5.26M |
LENSAR Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
---|---|---|---|---|
Europe | $5.58M | $4.41M | $5.80M | $3.59M |
UNITED STATES | $25.26M | $18.78M | $15.00M | $11.60M |
Other Geographical Region | $776.00K | $502.00K | $449.00K | $319.00K |
KOREA, REPUBLIC OF | $257.00K | $2.18M | $4.38M | $3.08M |
Asia Excluding South Korea | $3.84M | $3.58M | $3.85M | $4.19M |
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KOREA, REPUBLIC OF | $278.00K | $223.00K | $9.00K | $16.00K | $9.00K | $10.00K | $74.00K | $662.00K | $1.43M | $1.03M | $1.19M | $998.00K | $1.03M | $642.00K | - |
Asia Excluding South Korea | $884.00K | $896.00K | $1.10M | $1.13M | $708.00K | $1.09M | $932.00K | $771.00K | $780.00K | $1.40M | $1.28M | $633.00K | $542.00K | $746.00K | $1.46M |
Other Geographical Region | $54.00K | $102.00K | $481.00K | $89.00K | $104.00K | $129.00K | $98.00K | $137.00K | $138.00K | $173.00K | $115.00K | $96.00K | $65.00K | $95.00K | $87.00K |
UNITED STATES | $6.01M | $8.15M | $5.74M | $7.11M | $4.26M | $6.34M | $4.37M | $4.10M | $3.97M | $4.10M | $3.94M | $3.44M | $4.04M | $3.12M | - |
Europe | $1.42M | $1.13M | $934.00K | $1.98M | $1.54M | $1.03M | $805.00K | $956.00K | $1.62M | $3.09M | $908.00K | $921.00K | $889.00K | $1.29M | $761.00K |
U S | - | - | - | - | - | - | - | - | - | - | $3.52M | - | - | - | - |
K R | - | - | - | - | - | - | - | - | - | - | $1.17M | - | - | - | - |
LENSAR Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AXGN | AxoGen | $159.01M | $47.91M |
SRDX | Surmodics | $132.58M | $30.34M |
SIEN | Sientra | $90.55M | $19.54M |
RXST | RxSight | $89.08M | $45.52M |
SGHT | Sight Sciences | $81.06M | $21.37M |
LUNG | Pulmonx | $68.67M | $20.39M |
NPCE | NeuroPace | $65.42M | $18.12M |
IRIX | IRIDEX | $51.87M | $12.63M |
AZYO | Elutia | $49.19M | $6.13M |
LNSR | LENSAR | $42.16M | $10.59M |
SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
AIMD | Ainos | $122.11K | - |
OFIX | Orthofix Medical | $100.00K | $198.62M |
LNSR Revenue FAQ
What is LENSAR’s yearly revenue?
LENSAR's yearly revenue for 2023 was $42.16M, representing an increase of 19.25% compared to 2022. The company's yearly revenue for 2022 was $35.36M, representing an increase of 2.61% compared to 2021. LNSR's yearly revenue for 2021 was $34.46M, representing an increase of 30.62% compared to 2020.
What is LENSAR’s quarterly revenue?
LENSAR's quarterly revenue for Q1 2024 was $10.59M, a -12.53% decrease from the previous quarter (Q4 2023), and a 28.31% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $12.1M, a 23.58% increase from the previous quarter (Q3 2023), and a 18.31% increase year-over-year (Q4 2022). LNSR's quarterly revenue for Q3 2023 was $9.8M, a -18.46% decrease from the previous quarter (Q2 2023), and a 26.42% increase year-over-year (Q3 2022).
What is LENSAR’s revenue growth rate?
LENSAR's revenue growth rate for the last 3 years (2021-2023) was 22.36%, and for the last 5 years (2019-2023) was 38.12%.
What are LENSAR’s revenue streams?
LENSAR's revenue streams in c 23 are Service, and Product. Service generated $4.07M in revenue, accounting 11.40% of the company's total revenue, up 16.91% year-over-year. Product generated $31.64M in revenue, accounting 88.60% of the company's total revenue, up 21.90% year-over-year.
What is LENSAR’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of LENSAR was Product. This segment made a revenue of $31.64M, representing 88.60% of the company's total revenue.